ArticleFrontiers in oncology2023

Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma.

Caroline S Jansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.